Controlled Substance Management in Chronic Pain

1. Front Matter

   Pages i-xii

   PDF

2. Scope of the Pain Problem

   • Steven Chinn, Karina Gritsenko, Laxmaiah Manchikanti

   Pages 1-12

3. Scope of the Problem: Intersection of Chronic Pain and Addiction

   • Alicia A. Trigeiro, Kenneth L. Kirsh, Steven D. Passik

   Pages 13-27

4. Evidence-Based Treatment for Chronic Pain with Opioids

   • Sean Li, Peter S. Staats

   Pages 29-44

5. Opioid Pharmacology and Pharmacokinetics

   • Andrea M. Trescot

   Pages 45-62

6. Pharmacogenetics

   • Andrea M. Trescot

   Pages 63-73

7. Benzodiazepines, Alcohol, and Stimulant Use in Combination with Opioid Use

   • J. Gregory Hobelmann, Michael R. Clark

   Pages 75-86

8. Marijuana and Cannabinoids for Pain

   • Timothy Furnish, Mark Wallace

   Pages 87-109

9. Adjuvant Agents in Chronic Pain Therapy

   • Joseph V. Pergolizzi

   Pages 111-134

10. Complications of Opioid Therapy

    • Gerald M. Aronoff

    Pages 135-161

11. Risk Mitigation Strategies

    • Lynn R. Webster

    Pages 163-180

12. Naloxone Treatment of Opioid Overdose

    • Sanford M. Silverman, Peter S. Staats

    Pages 181-186

13. From Patient Evaluation to Opioid Overdose Prevention: Ten Steps to Make the Law Work for You and Your Patients

    • Jen Bolen

    Pages 187-226

14. Treating the Difficult Patient

    • Hans Hansen, Judith Holmes

    Pages 227-250

15. Controlled Substance Management: Exit Strategies for the Pain Practitioner

    • Sanford M. Silverman

    Pages 251-280

16. Alternatives to Opiates in the Management of Non-cancer-related Pain

    • Peter S. Staats, Sean Li, Sanford M. Silverman

    Pages 281-295

17. Back Matter

    Pages 297-323

    PDF

This comprehensive guide covers prescribing controlled substances for patients with acute or chronic pain and provides a balanced discussion on appropriate treatment, addiction, safety and complications.  Chapters feature evidence-based strategies and clinical modalities that address diagnostic challenges, treatment guidance, alternatives to opioid management and the significant legal risks within the current regulatory environment.  Authored by leaders in pain medicine, physicians and appropriate health care professionals will find Controlled Substance Management in Chronic Pain to be an indispensable resource. 

• Adujvant agents
• Controlled Substance Management
• DEA
• Opioid risk
• Pharmacogenetics
• cannabanoids
• chronic pain
• legal aspects
• opioids
• pain problem
• pharmacokinetics
• pharmacology
• practice management
• pharmacotherapy
• pharmacoeconomics

“Clinicians who care for patients with chronic pain on a regular basis in their practice are the intended audience. … It helps to make sense of the chaotic world of opioid therapy for chronic conditions. I cannot think of any other book that comes close to doing justice to this important topic. This is a must read for all pain physicians at all levels of training and experience.” (Tariq M. Malik, Doody's Book Reviews, August, 2016)

• Shrewsbury, USA

  Peter S. Staats

• Comprehensive Pain Medicine, Pompano Beach, USA

  Sanford M. Silverman

Peter S. Staats, MD, MBA, FIPP ABIPP
President, American Society of Interventional Pain Physicians
Johns Hopkins University
Department of Anesthesiology and Critical Care, and Department of Oncology
Premier Pain Centers 
Shrewsbury, NJ 



 

 
Sanford M. Silverman, MD, DABPM, DABAM
CEO and Medical Director of Comprehensive Pain Medicine, Pompano Beach, FL<Department of Anesthesiology, Affiliate Assistant Professor of Clinical Biomedical Science, Charles E. Schmidt College of Medicine, Florida Atlantic University
Department of Surgery,  Boca Raton Regional Hospital
Department of Surgery,  Broward North Medical Center